HighTower Advisors’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-29,262
| Closed | -$820K | – | 3666 |
|
|
2022
Q1 | $820K | Hold |
29,262
| – | – | ﹤0.01% | 1869 |
|
|
2021
Q4 | $799K | Hold |
29,262
| – | – | ﹤0.01% | 1882 |
|
|
2021
Q3 | $796K | Hold |
29,262
| – | – | ﹤0.01% | 1785 |
|
|
2021
Q2 | $500K | Hold |
29,262
| – | – | ﹤0.01% | 2046 |
|
|
2021
Q1 | $611K | Hold |
29,262
| – | – | ﹤0.01% | 1853 |
|
|
2020
Q4 | $670K | Buy |
+29,262
| New | +$557K | ﹤0.01% | 1470 |
|
|
2020
Q1 | – | Sell |
-8,477
| Closed | -$211K | – | 2581 |
|
|
2019
Q4 | $211K | Buy |
+8,477
| New | +$172K | ﹤0.01% | 1941 |
|
|
2019
Q2 | – | Sell |
-8,628
| Closed | -$277K | – | 2557 |
|
|
2019
Q1 | $277K | Hold |
8,628
| – | – | ﹤0.01% | 1752 |
|
|
2018
Q4 | $242K | Sell |
8,628
-835
| -9% | -$24.5K | ﹤0.01% | 1720 |
|
|
2018
Q3 | $273K | Buy |
9,463
+1,201
| +15% | +$36.1K | ﹤0.01% | 1774 |
|
|
2018
Q2 | $310K | Sell |
8,262
-2,732
| -25% | -$107K | ﹤0.01% | 1671 |
|
|
2018
Q1 | $434K | Buy |
10,994
+2,732
| +33% | +$99.8K | ﹤0.01% | 1491 |
|
|
2017
Q4 | $267K | Hold |
8,262
| – | – | ﹤0.01% | 1759 |
|
|
2017
Q3 | $257K | Hold |
8,262
| – | – | ﹤0.01% | 1770 |
|
|
2017
Q2 | $231K | Buy |
+8,262
| New | +$187K | ﹤0.01% | 1776 |
|
|
2016
Q3 | – | Sell |
-10,440
| Closed | -$134K | – | 1976 |
|
|
2016
Q2 | $134K | Buy |
+10,440
| New | +$163K | ﹤0.01% | 1574 |
|
|
2015
Q3 | – | Sell |
-26,565
| Closed | -$761K | – | 1975 |
|
|
2015
Q2 | $761K | Sell |
26,565
-641
| -2% | -$16.8K | 0.01% | 864 |
|
|
2015
Q1 | $703K | Buy |
+27,206
| New | +$622K | 0.01% | 948 |
|
HighTower Advisors's XENT Position: Q2 2022 in Review
HighTower Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 29,262 shares — an estimated $820K sold.
HighTower Advisors first reported a position in XENT in Q1 2015 and held it in 18 quarters. The position peaked at $820K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- HighTower Advisors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- HighTower Advisors sold 29,262 Intersect ENT, Inc shares in Q2 2022, an estimated $820K.
- HighTower Advisors first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 18 quarters.
- HighTower Advisors's Intersect ENT, Inc position peaked at $820K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on HighTower Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.